Latest accounts payable for DMAQU: $3.2M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), DMAQU shows a accounts payable of $3.2M. That compares with $2.6M in the prior-year period — up 24.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, DMAQU's accounts payable is now $3.2M (was $2.6M) — a 24.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) is outperforming or lagging.
Tracking DMAQU's accounts payable over time shows whether Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.2M That compares with $2.6M in the prior-year period — up 24.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this accounts payable page, Stockcircle has Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $3.2M) with ownership activity and broader fundamentals.